These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 35144840)

  • 1. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
    Mottl AK; Alicic R; Argyropoulos C; Brosius FC; Mauer M; Molitch M; Nelson RG; Perreault L; Nicholas SB
    Am J Kidney Dis; 2022 Apr; 79(4):457-479. PubMed ID: 35144840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD.
    Mottl AK; Nicholas SB
    Am J Kidney Dis; 2024 Mar; 83(3):277-287. PubMed ID: 38142396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD.
    Drawz PE; Beddhu S; Bignall ONR; Cohen JB; Flynn JT; Ku E; Rahman M; Thomas G; Weir MR; Whelton PK
    Am J Kidney Dis; 2022 Mar; 79(3):311-327. PubMed ID: 35063302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment.
    de Boer IH; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Khunti K; Liew A; Michos ED; Navaneethan SD; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Zoungas S; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Rossing P
    Kidney Int; 2020 Oct; 98(4):839-848. PubMed ID: 32653403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
    Navaneethan SD; Zoungas S; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Liew A; Michos ED; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Craig JC; Tunnicliffe DJ; Tonelli M; Cheung M; Earley A; Rossing P; de Boer IH; Khunti K
    Ann Intern Med; 2023 Mar; 176(3):381-387. PubMed ID: 36623286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
    Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
    Agarwal A; Zeng X; Li S; Rayner D; Foroutan F; Aertgeerts B; Coyac F; Farhoumand PD; Demaine A; Heen AF; Jha V; Machuve E; Nagler E; Tunnicliffe DJ; Guyatt GH; Vandvik PO; Ponte B; Agoritsas T
    BMJ; 2024 Oct; 387():e080257. PubMed ID: 39353639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
    de Boer IH; Khunti K; Sadusky T; Tuttle KR; Neumiller JJ; Rhee CM; Rosas SE; Rossing P; Bakris G
    Kidney Int; 2022 Nov; 102(5):974-989. PubMed ID: 36202661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
    Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
    Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners.
    Kushner P; Khunti K; Cebrián A; Deed G
    Adv Ther; 2024 Oct; 41(10):3757-3770. PubMed ID: 39162984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
    Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
    Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
    Iatridi F; Carrero JJ; Gall EC; Kanbay M; Luyckx V; Shroff R; Ferro CJ
    Nephrol Dial Transplant; 2024 Sep; ():. PubMed ID: 39299913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA1c and beyond.
    Rossing P
    Nephrol Dial Transplant; 2023 Jan; 38(1):34-40. PubMed ID: 34383945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New guideline on diabetes management in chronic kidney disease].
    Wanner C; Busch M
    Inn Med (Heidelb); 2023 Mar; 64(3):219-224. PubMed ID: 36745249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.
    Rossing P; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Khunti K; Liew A; Michos ED; Navaneethan SD; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Zoungas S; Craig JC; Tunnicliffe DJ; Tonelli MA; Cheung M; Earley A; de Boer IH
    Kidney Int; 2022 Nov; 102(5):990-999. PubMed ID: 36272755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study.
    Forbes AK; Hinton W; Feher MD; Elson W; Joy M; Ordóñez-Mena JM; Fan X; Cole NI; Banerjee D; Suckling RJ; de Lusignan S; Swift PA
    EClinicalMedicine; 2024 Feb; 68():102426. PubMed ID: 38304744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.